Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions

Metabolic SyndromeDyslipidemia

Interventions

DRUG

Rosuvastatin

Trial Locations (1)

Research Site, Melbourne